메뉴 건너뛰기




Volumn 15, Issue 15, 2014, Pages 2117-2120

Are we near to an effective drug treatment for bronchiolitis obliterans?

Author keywords

Bronchiolitis obliterans; Bronchiolitis obliterans syndrome; Lung transplantation; Treatment

Indexed keywords

AZITHROMYCIN; IMMUNOSUPPRESSIVE AGENT; MONTELUKAST;

EID: 84907259387     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2014.954549     Document Type: Review
Times cited : (11)

References (20)
  • 1
    • 84895057011 scopus 로고    scopus 로고
    • A new classification system for lung allograft dysfunction
    • Verleden GM, Raghu G, Meyer KC, et al. A new classification system for lung allograft dysfunction. J Heart Lung Transplant 2014;33:127-33
    • (2014) J Heart Lung Transplant , vol.33 , pp. 127-133
    • Verleden, G.M.1    Raghu, G.2    Meyer, K.C.3
  • 2
    • 84884292762 scopus 로고    scopus 로고
    • International society for heart and lung transplantation. The registry of the international society for heart and lung transplantation: Thirtieth adult lung and heart-lung transplant report-2013; Focus theme: Age
    • Yusen RD, Christie JD, Edwards LB, International Society for Heart and Lung Transplantation. The registry of the International Society for Heart and Lung Transplantation: thirtieth adult lung and heart-lung transplant report-2013; focus theme: age. J Heart Lung Transplant 2013;32:965-78
    • (2013) J Heart Lung Transplant , vol.32 , pp. 965-978
    • Yusen, R.D.1    Christie, J.D.2    Edwards, L.B.3
  • 3
    • 84891681620 scopus 로고    scopus 로고
    • Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients
    • Penninga L, Penninga EI, Møller CH, et al. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. Cochrane Database Syst Rev 2013;5:CD008817
    • (2013) Cochrane Database Syst Rev , vol.5 , pp. CD008817
    • Penninga, L.1    Penninga, E.I.2    Møller, C.H.3
  • 4
    • 84889069860 scopus 로고    scopus 로고
    • Immunosuppression and allograft rejection following lung transplantation: Evidence to date
    • Snell GI, Westall GP, Paraskeva MA. Immunosuppression and allograft rejection following lung transplantation: evidence to date. Drugs 2013;73:1793-813
    • (2013) Drugs , vol.73 , pp. 1793-1813
    • Snell, G.I.1    Westall, G.P.2    Paraskeva, M.A.3
  • 5
    • 79960948356 scopus 로고    scopus 로고
    • Fundoplication after lung transplantation prevents the allograft dysfunction associated with reflux
    • Hartwig MG, Anderson DJ, Onaitis MW, et al. Fundoplication after lung transplantation prevents the allograft dysfunction associated with reflux. Ann Thorac Surg 2011;92:462-8
    • (2011) Ann Thorac Surg , vol.92 , pp. 462-468
    • Hartwig, M.G.1    Anderson, D.J.2    Onaitis, M.W.3
  • 6
    • 79251591304 scopus 로고    scopus 로고
    • A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation
    • Vos R, Vanaudenaerde BM, Verleden SE, et al. A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation. Eur Respir J 2011;37:164-72
    • (2011) Eur Respir J , vol.37 , pp. 164-172
    • Vos, R.1    Vanaudenaerde, B.M.2    Verleden, S.E.3
  • 7
    • 30444434900 scopus 로고    scopus 로고
    • A randomized trial of inhaled cyclosporine in lung-transplant recipients
    • Iacono AT, Johnson BA, Grgurich WF, et al. A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med 2006;354:141-50
    • (2006) N Engl J Med , vol.354 , pp. 141-150
    • Iacono, A.T.1    Johnson, B.A.2    Grgurich, W.F.3
  • 8
    • 0037096617 scopus 로고    scopus 로고
    • Addition of inhaled corticosteroids to systemic immunosuppression after lung transplantation: A double-blind, placebo-controlled trial
    • Whitford H, Walters EH, Levvey B, et al. Addition of inhaled corticosteroids to systemic immunosuppression after lung transplantation: a double-blind, placebo-controlled trial. Transplantation 2002;73:1793-9
    • (2002) Transplantation , vol.73 , pp. 1793-1799
    • Whitford, H.1    Walters, E.H.2    Levvey, B.3
  • 9
    • 77957028167 scopus 로고    scopus 로고
    • Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients
    • Finlen Copeland CA, Snyder LD, Zaas DW, et al. Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients. Am J Respir Crit Care Med 2010;182:784-9
    • (2010) Am J Respir Crit Care Med , vol.182 , pp. 784-789
    • Finlen Copeland, C.A.1    Snyder, L.D.2    Zaas, D.W.3
  • 10
    • 79960555865 scopus 로고    scopus 로고
    • A review of bronchiolitis obliterans syndrome and therapeutic strategies
    • Hayes D Jr. A review of bronchiolitis obliterans syndrome and therapeutic strategies. J Cardiothorac Surg 2011;6:92
    • (2011) J Cardiothorac Surg , vol.6 , pp. 92
    • Hayes, D.1
  • 12
    • 84864278385 scopus 로고    scopus 로고
    • Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection
    • Vos R, Vanaudenaerde BM, Verleden SE, et al. Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection. Transplantation 2012;94:101-9
    • (2012) Transplantation , vol.94 , pp. 101-109
    • Vos, R.1    Vanaudenaerde, B.M.2    Verleden, S.E.3
  • 13
    • 38148998845 scopus 로고    scopus 로고
    • Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation
    • Gottlieb J, Szangolies J, Koehnlein T, et al. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation. Transplantation 2008;85:36-41
    • (2008) Transplantation , vol.85 , pp. 36-41
    • Gottlieb, J.1    Szangolies, J.2    Koehnlein, T.3
  • 14
    • 79959845442 scopus 로고    scopus 로고
    • Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A pilot study
    • Verleden GM, Verleden SE, Vos R, et al. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study. Transpl Int 2011;24:651-6
    • (2011) Transpl Int , vol.24 , pp. 651-656
    • Verleden, G.M.1    Verleden, S.E.2    Vos, R.3
  • 15
    • 84874409607 scopus 로고    scopus 로고
    • TNFa from classically activated macrophages accentuates epithelial to mesenchymal transition in obliterative bronchiolitis
    • Borthwick LA, Corris PA, Mahida R, et al. TNFa from classically activated macrophages accentuates epithelial to mesenchymal transition in obliterative bronchiolitis. Am J Transplant 2013;13:621-33
    • (2013) Am J Transplant , vol.13 , pp. 621-633
    • Borthwick, L.A.1    Corris, P.A.2    Mahida, R.3
  • 16
    • 84864956150 scopus 로고    scopus 로고
    • A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation
    • Jaksch P, Scheed A, Keplinger M, et al. A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 2012;31:950-7
    • (2012) J Heart Lung Transplant , vol.31 , pp. 950-957
    • Jaksch, P.1    Scheed, A.2    Keplinger, M.3
  • 17
    • 84875723226 scopus 로고    scopus 로고
    • Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients
    • Greer M, Dierich M, De Wall C, et al. Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients. Am J Transplant 2013;13:911-18
    • (2013) Am J Transplant , vol.13 , pp. 911-918
    • Greer, M.1    Dierich, M.2    De Wall, C.3
  • 18
    • 14644391619 scopus 로고    scopus 로고
    • The safety and efficacy of total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation
    • Fisher AJ, Rutherford RM, Bozzino J, et al. The safety and efficacy of total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant 2005;5:537-43
    • (2005) Am J Transplant , vol.5 , pp. 537-543
    • Fisher, A.J.1    Rutherford, R.M.2    Bozzino, J.3
  • 19
    • 79954626470 scopus 로고    scopus 로고
    • Lung retransplantation
    • Kawut SM. Lung retransplantation. Clin Chest Med 2011;32:367-77
    • (2011) Clin Chest Med , vol.32 , pp. 367-377
    • Kawut, S.M.1
  • 20
    • 84893606611 scopus 로고    scopus 로고
    • The site and nature of airway obstruction after lung transplantation
    • Verleden SE, Vasilescu DM, Willems S, et al. The site and nature of airway obstruction after lung transplantation. Am J Respir Crit Care Med 2014;189:292-300
    • (2014) Am J Respir Crit Care Med , vol.189 , pp. 292-300
    • Verleden, S.E.1    Vasilescu, D.M.2    Willems, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.